Antibody humanization using monovalent phage display
- PMID: 9099717
- DOI: 10.1074/jbc.272.16.10678
Antibody humanization using monovalent phage display
Abstract
Antibody humanization often requires the replacement of key residues in the framework regions with corresponding residues from the parent non-human antibody. These changes are in addition to grafting of the antigen-binding loops. Although guided by molecular modeling, assessment of which framework changes are beneficial to antigen binding usually requires the analysis of many different antibody mutants. Here we describe a phage display method for optimizing the framework of humanized antibodies by random mutagenesis of important framework residues. We have applied this method to humanization of the anti-vascular endothelial growth factor murine monoclonal antibody A4.6.1. Affinity panning of a library of humanized A4.6.1 antibody mutants led to the selection of one variant with greater than 125-fold enhanced affinity for antigen relative to the initial humanized antibody with no framework changes. A single additional mutation gave a further 6-fold improvement in binding. The affinity of this variant, 9.3 nM, was only 6-fold weaker than that of a murine/human chimera of A4.6.1. This method provides a general means of rapidly selecting framework mutations that improve the binding of humanized antibodies to their cognate antigens and may prove an attractive alternative to current methods of framework optimization based on cycles of site-directed mutagenesis.
Similar articles
-
Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.Cancer Res. 1997 Oct 15;57(20):4593-9. Cancer Res. 1997. PMID: 9377574
-
Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.J Mol Biol. 1999 Nov 5;293(4):865-81. doi: 10.1006/jmbi.1999.3192. J Mol Biol. 1999. PMID: 10543973
-
Selection of antibody single-chain variable fragments with improved carbohydrate binding by phage display.J Biol Chem. 1994 Apr 1;269(13):9533-8. J Biol Chem. 1994. PMID: 8144539
-
Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.J Mol Recognit. 1999 Jan-Feb;12(1):19-32. doi: 10.1002/(SICI)1099-1352(199901/02)12:1<19::AID-JMR445>3.0.CO;2-Y. J Mol Recognit. 1999. PMID: 10398393 Review.
-
Humanization of antibodies.Front Biosci. 2008 Jan 1;13:1619-33. doi: 10.2741/2786. Front Biosci. 2008. PMID: 17981654 Review.
Cited by
-
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions.Cell Rep Med. 2021 Jun 15;2(6):100313. doi: 10.1016/j.xcrm.2021.100313. Epub 2021 May 21. Cell Rep Med. 2021. PMID: 34056628 Free PMC article.
-
Computational optimization of antibody humanness and stability by systematic energy-based ranking.Nat Biomed Eng. 2024 Jan;8(1):30-44. doi: 10.1038/s41551-023-01079-1. Epub 2023 Aug 7. Nat Biomed Eng. 2024. PMID: 37550425 Free PMC article.
-
DNA-encoded chemistry: enabling the deeper sampling of chemical space.Nat Rev Drug Discov. 2017 Feb;16(2):131-147. doi: 10.1038/nrd.2016.213. Epub 2016 Dec 9. Nat Rev Drug Discov. 2017. PMID: 27932801 Review.
-
Protein and Antibody Engineering by Phage Display.Methods Enzymol. 2016;580:45-87. doi: 10.1016/bs.mie.2016.05.005. Epub 2016 Jun 29. Methods Enzymol. 2016. PMID: 27586328 Free PMC article.
-
Molecular engineering of antibodies for therapeutic and diagnostic purposes.MAbs. 2012 Jul-Aug;4(4):445-57. doi: 10.4161/mabs.20776. Epub 2012 Jul 1. MAbs. 2012. PMID: 22684311 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources